Literature DB >> 14140032

THE PHARMACOLOGY AND BIOCHEMISTRY OF DEPRESSION.

A J PRANGE.   

Abstract

Keywords:  AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; BIOCHEMISTRY; BRAIN; BRAIN ENZYMOLOGY; DEPRESSION; EPINEPHRINE; HYPERTHYROIDISM; HYPOTHYROIDISM; IMIPRAMINE; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; PHARMACOLOGY; RESERPINE; SEROTONIN; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14140032

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN： 0012-3714


× No keyword cloud information.
  13 in total

Review 1.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

2.  Stuck in a rut: rethinking depression and its treatment.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  Trends Neurosci       Date:  2010-11-08       Impact factor: 13.837

Review 3.  New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.

Authors:  Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  Depress Anxiety       Date:  2017-05-10       Impact factor: 6.505

4.  Role of TrkB in the anxiolytic-like and antidepressant-like effects of vagal nerve stimulation: Comparison with desipramine.

Authors:  A P Shah; F R Carreno; H Wu; Y A Chung; A Frazer
Journal:  Neuroscience       Date:  2016-02-16       Impact factor: 3.590

Review 5.  Vagal Nerve Stimulation for Treatment-Resistant Depression.

Authors:  Flavia R Carreno; Alan Frazer
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

6.  Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

Authors:  V Klimek; C Stockmeier; J Overholser; H Y Meltzer; S Kalka; G Dilley; G A Ordway
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.

Authors:  Maria T G Perona; Shonna Waters; Frank Scott Hall; Ichiro Sora; Klaus-Peter Lesch; Dennis L Murphy; Marc Caron; George R Uhl
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

8.  Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Nieves Herrera-Mundo; Catherine E Sykes; Dina M Francescutti; Donald M Kuhn
Journal:  ACS Chem Neurosci       Date:  2014-08-12       Impact factor: 4.418

Review 9.  Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.

Authors:  Lynette C Daws
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

Review 10.  Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Authors:  W Z Potter
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.